PECAM1 and leprosy: The aim of this study was to evaluate angiogenesis and lymphangiogenesis across the spectrum of leprosy, in its reactional episodes and in its residual lesions by immunohistochemistry (IHC), using the markers CD31, CD105/endoglin and D2-40/podoplanin [8–11].